WARF Therapeutics

Invest-Develop-Partner

Jump to section:

WARF Therapeutics Portfolio

Drug discovery research is a complex multi-disciplinary process. WARF Therapeutics brings together industry caliber drug discovery capabilities through strategic partnerships and internal medicinal chemistry expertise to interrogate novel validated targets discovered at the University of Wisconsin-Madison.

Through disciplined application of resources and stage gate milestones, we will move programs towards optimized novel molecules that demonstrate in vivo proof of concept and supports the therapeutic hypothesis.  We will advance suitably de-risked programs to clinical testing through a variety of mechanisms including licensing, investment partnerships, or start-up companies. Our portfolio consists of programs that have achieved a high degree of pre-clinical validation, span a spectrum of therapeutic areas, and are focused on improving the lives of patients with unmet medical needs.